"Carcinoma, Ductal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.
Descriptor ID |
D044584
|
MeSH Number(s) |
C04.557.470.200.025.232 C04.557.470.615.132
|
Concept/Terms |
Carcinoma, Ductal- Carcinoma, Ductal
- Carcinomas, Ductal
- Ductal Carcinomas
- Ductal Carcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ductal".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ductal".
This graph shows the total number of publications written about "Carcinoma, Ductal" by people in this website by year, and whether "Carcinoma, Ductal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2004 | 5 | 1 | 6 |
2005 | 0 | 5 | 5 |
2006 | 6 | 2 | 8 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 2 | 0 | 2 |
2012 | 1 | 0 | 1 |
2013 | 1 | 2 | 3 |
2014 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2017 | 0 | 1 | 1 |
2018 | 3 | 2 | 5 |
2019 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
2021 | 4 | 0 | 4 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Ductal" by people in Profiles.
-
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin. J Cutan Pathol. 2024 May; 51(5):360-367.
-
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified. Cancer. 2022 02 01; 128(3):509-518.
-
Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations. Clin Cancer Res. 2021 07 15; 27(14):3960-3969.
-
Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol. 2021 06; 18(6):337-358.
-
The tumor immune contexture of salivary duct carcinoma. Head Neck. 2021 04; 43(4):1213-1219.
-
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99.
-
Patterns of metastases of prostatic ductal adenocarcinoma. Cancer. 2020 08 15; 126(16):3667-3673.
-
Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma. Clin Cancer Res. 2020 03 01; 26(5):1175-1184.
-
Salivary gland tumors: Molecular characterization and therapeutic advances for metastatic disease. Head Neck. 2019 01; 41(1):239-247.
-
Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma. Head Neck Pathol. 2019 Dec; 13(4):529-534.